In many ways, financial/investing terminology is a language all to itself. Reading financial earnings calls transcripts or press releases is a good practice that helps you develop your understanding of these terms, but chances are you will still come across some that you haven't used before for at least your first few earnings call seasons. In these situations, it's important to know what you DON'T know so that you can research anything that is at all unfamiliar.
For example, a speaker may say what sounds like "S. G. N. A.," but what they're really referring to is SG&A, which is selling, general and administrative expenses.
Another example of an acronym that has a misleading pronounciation is CAGR, or compound annual growth rate, which is not prounounced as "C. A. G. R." but rather as "kay-ger."
Others include:
- ARPU (which, by the way, I love to say!), average revenue per user, or "ar-poo"
- EBITDA, earnings before interest, taxes, depreciation and amortization, or "ee-bit-ah"
- GAAP or non-GAAP, generally accepted accounting principles, or "gap"
The following sites all offer comprehensive, searchable databases as well:
Investor Words
Yahoo! Finance
Investopedia
Finally, here is a list of terminology. Please note that this list is not comprehensive, but it does cover a lot of the most common terms. I hope to continue adding definitions to the list for your reference, but having the correct term in front of you is more than half the battle!
Terms/Acronyms | Definition |
---|---|
accrual, accretive, accrue | growing in size |
ADR | American Depository Receipt |
ANDA (ay en dee ay) | abbreviated new drug application |
annualized | financial figurextrapolate a value for a given time period to reflect a full year value |
antigens (medical term) | |
AP | accounts payable |
apples-to-apples | to compare like values |
ARPU (ar poo) | average revenue per user |
APR | annual percentage rate |
ASP | average selling price |
assay | |
AR | accounts receivable |
B2B | business to business |
backwardation | when futures prices are lower in the long term than the near term |
Big Pharma, pharma | short form for pharmaceutical companies |
BOE | barrel of oil equivalent |
book-to-bill ratio (semiconductor industry) | |
BP | basis point |
BPD | barrels per day |
brownfield | |
buy side/sell side | analyst coverage of stocks |
CAGR | compound annual growth rate |
CapEx | capital expenditures |
cath lab (medical term) | |
churn | rate of customer attrition |
CLEC (see-lek)(telecom) | competitive local exchange carrier |
COGS | cost of goods sold |
comp, comps, comp store sales | |
contango | upward sloping forward curve in the futures market |
covenant | loan agreement |
CRM | customer relationship management |
de novo | financial reports of a new/young company |
dilutive | |
DSOs | days sales outstanding |
EAFE | Europe and Australia Far East Equity Index |
e-business | |
EBITDA, EBIT, EDITDAX (ee bit uh) | earnings before interest, depreciation and amortization |
e-government | |
EITF (accounting standards) | Emerging Issues Task Force |
EMEA | Europe, Middle East and Asia |
EPS | earnings per share |
escrow | |
ETA/ETD | estimated time of arrival/departure |
fab, wafer fab | short for fabrication |
FAS 142, FAS 143 | financial accounting standard |
FASB 123(R), FAS 123(R) | |
FASB | Financial Accounting Standards Board |
FDA | Food and Drug Administration |
FERC (ferk) | Federal Energy Regulatory Commissions |
FFO | funds from operations |
FICO | credit score |
FIFO | first in, first out |
FIN (financial standard) | |
First Call | analyst reference |
fiscal | |
follow-up | additional question |
Form 10-K, 8-K 10-Q | SEC forms |
free cash flow | |
FX | foreign exchange |
GAAP, non-GAAP (gap) | generally accepted accounting principles |
FY | fiscal year |
GM | gross margin |
greenfield | |
headcount | |
HMO | health management organization |
ILEC (eye-lek) | |
in vivo | |
IPO | initial public offering |
JV | joint venture |
kinase | |
LIBOR | London Interbank Offered Rate |
LIFO | last in, first out |
link-quarter | |
liquidity | |
LOE | lease operating expenses |
LY, HY, FY, FY '04 | last year, half year, full year, full year ‘04 |
M&A | mergers and acquisitions |
mark-to-market | |
Mcfe (resource sector term) | |
MD&A | management discussion and analysis |
metric, metrics | |
Mmbtu (exploration) | one million British thermal units |
NAREIT | board governing REITs |
NDA | new drug application |
NOI | net operating income |
NOLs | |
NYMEX | New York Mercantile Exchange |
OEM | original equipment manufacturer |
OpEx | operating expenses |
OPM | original product manufacturer |
P/E | price/earnings (ratio) |
P&L or P/L | profit and loss |
pharmacokinetics, pharmacogenomics | |
Phase I, II, III, IIa | clinical trials on medical/pharma calls |
pari passu | |
Private Securities Litigation Reform Act | |
pro forma | |
protease inhibitor | |
proteomics | |
puts, swaps, calls | stock trading terms |
Q1, Q2, Q3, Q4, Q4 '04, Q2 '03 | 1st quarter, 2nd quarter, etc. |
QA | quality assurance |
Q | abbreviation for Form 10-Q |
queue | line up, as in queue for Q&A period |
R&D | research and development |
ramp up | |
reagent | |
Regulation FD, Reg FD | |
REIT (reet) | real estate investment trust |
Reuters | |
RevPAR | revenue per available room |
ROA | return on assets |
ROE | return on equity |
ROI | return on investment |
ROIC | return on invested capital |
run rate | |
S&P | Standard & Poor's |
SAC | subscriber acquisition costs |
Safe Harbor provisions | |
Sarbanes-Oxley Act, SOX, SarbOx | |
SEC | Securities and Exchange Commission |
SG&A, G&A | selling, general and administrative costs |
share repurchase | |
Six Sigma | |
SKU (skew) | stock keeping unit |
spend (noun) | the amount spent |
spud (oilfield term) | |
stent, shunt | |
stock buy-back | |
TBA/TBD | to be announced/determined |
the Street (the City in the UK) | the analyst community |
The Patriot Act | |
top line, bottom line | |
tranche, traunche | |
true up | |
turnkey system | |
turns (inventory) | |
VoIP | Voice over Internet Protocol |
webcast | |
website | |
wellhead | |
YTD | year to date |

1 Comment:
I want to thank you for listing these definitions!
I recently started doing some contract work for an IR company and have no experience in transcription other than medical, so this is very helpful for me!
I look forward to exploring your site in more depth over time.
Post a Comment